Compare ZLAB & NTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZLAB | NTB |
|---|---|---|
| Founded | 2013 | 1858 |
| Country | China | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.3B |
| IPO Year | 2017 | 2016 |
| Metric | ZLAB | NTB |
|---|---|---|
| Price | $19.77 | $59.40 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | $49.60 | ★ $53.75 |
| AVG Volume (30 Days) | ★ 888.8K | 214.6K |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 3.66% |
| EPS Growth | ★ 38.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $460,156,000.00 | N/A |
| Revenue This Year | $9.75 | $0.84 |
| Revenue Next Year | $26.03 | $4.16 |
| P/E Ratio | ★ N/A | $9.64 |
| Revenue Growth | ★ 15.33 | N/A |
| 52 Week Low | $15.96 | $40.59 |
| 52 Week High | $41.20 | $61.11 |
| Indicator | ZLAB | NTB |
|---|---|---|
| Relative Strength Index (RSI) | 62.65 | 54.59 |
| Support Level | $19.51 | $57.71 |
| Resistance Level | $20.25 | N/A |
| Average True Range (ATR) | 0.75 | 1.02 |
| MACD | 0.24 | -0.01 |
| Stochastic Oscillator | 99.24 | 51.69 |
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It offers banking services, comprising retail and corporate banking, and wealth management services, which consist of trust, private banking, and asset management business. The company operates through four reportable segments: Bermuda, Cayman, Channel Islands and the UK, and Other. In its Bermuda and Cayman segments, the company offers retail banking and wealth management services. In the Channel Islands and the UK segment, the company offers retail and corporate banking and wealth management services, and the Other segment includes its operations in the Bahamas, Canada, Mauritius, Singapore, and Switzerland. Maximum revenue for the company is generated from its business in Bermuda.